Cell Painting PLUS reveals phenotypic signatures for nephrotoxicity profiling in human RPTEC/TERT1
This study demonstrates that Cell Painting PLUS applied to human RPTEC/TERT1 cells effectively identifies distinct morphological signatures for over 300 compounds, enabling mechanistic nephrotoxicity profiling and highlighting the critical importance of using physiologically relevant cell models for Next Generation Risk Assessment.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of a preprint that has not been peer-reviewed. It is not medical advice. Do not make health decisions based on this content. Read full disclaimer
To understand how new medicines might hurt the human body, scientists often look at how chemicals change the shape and behavior of cells. For decades, this work relied heavily on testing animals, but a modern push called Next Generation Risk Assessment aims to replace those tests with faster, more human-relevant methods. Instead of watching a whole animal, researchers now use tiny, living cells in a dish to see how they react to a chemical. One powerful way to do this is by taking thousands of high-resolution photographs of the cells and measuring their features, such as the size of their nucleus or the texture of their internal structures. This process, known as high-content imaging, creates a detailed "fingerprint" for each chemical. If a chemical changes a cell's fingerprint in a specific way, scientists can often guess what part of the cell's machinery the chemical is attacking. The goal is to spot dangerous drugs early, before they ever reach a patient, by finding these unique biological signatures in a test tube.
A team of researchers recently applied this imaging technique to a specific type of human kidney cell to see if they could better predict kidney damage. They used a cell line called RPTEC/TERT1, which is grown from human kidney tissue and behaves much like the cells that line the kidney's filtering tubes. The scientists treated these cells with hundreds of different chemicals, including known kidney toxins, growth factors, and a large set of reference drugs with known targets. They used an advanced imaging method called Cell Painting PLUS, which stains the cells with multiple dyes to highlight different internal parts like the mitochondria, the DNA, and the cell's skeleton. By taking pictures and analyzing thousands of tiny details, they created a massive map of how each chemical altered the kidney cells.
The results showed that the kidney cells responded in very specific ways depending on the type of poison they faced. Some chemicals, like heavy metals, caused widespread chaos across the entire cell, damaging almost every internal part. Others were more precise. For instance, certain drugs that damage DNA caused the cell's genetic material to look different, while others that stressed the cell's protein-making factories caused the internal membranes to swell. The researchers found that they could group chemicals together based on these visual changes. Even drugs that worked in opposite ways, such as one that increased the brightness of a specific cell part and another that decreased it, were easily distinguished. This level of detail allowed the team to sort chemicals by their mechanism of action, essentially organizing them by how they break the cell, rather than just by whether they killed it.
A key part of the study involved comparing these human kidney cells to a different, more commonly used cell line called U2OS, which comes from a bone tumor. The bone cells were much more sensitive; they reacted strongly to many chemicals and died more easily. In contrast, the kidney cells were tougher and showed fewer dramatic changes. At first, this might seem like a disadvantage, but the researchers argued it was actually a sign of a more realistic model. The kidney cells maintained their natural, tightly packed structure and resisted damage in a way that mirrored how real human kidneys often behave. When the team looked at specific drugs, they found that the kidney cells were better at showing the unique signatures of kidney-related problems, such as changes in the cell's skeleton or energy centers, while the bone cells were better at showing signs of DNA damage. This suggests that using a cell type that matches the organ being studied is more important than simply using the cell that reacts the most violently.
The study also revealed that the kidney cells could detect subtle differences between drugs that target the same pathway. For example, when testing drugs that block a specific signaling pathway involved in cell growth, the kidney cells produced very similar visual patterns for drugs that worked the same way, but different patterns for drugs that worked differently. This ability to distinguish between similar and opposing effects was less clear in the bone cells. The researchers concluded that while the kidney cells were less reactive overall, their responses were more biologically meaningful for understanding kidney toxicity. They demonstrated that this imaging approach, when applied to the right type of human cell, can provide a clear, detailed picture of how chemicals threaten the kidney, offering a powerful new tool for safety testing that relies on human biology rather than animal models.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.